RePub, Erasmus University Repository

Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer Article

International Journal of Cancer, 100(3), 309-317.

K. Steketee (Karine), L. Timmerman (Leon), A.C.J. Ziel-van der Made (Angelique), P. Doesburg (Paul), A.O. Brinkmann (Albert) and J. Trapman (Jan)

July 2002
Sequelae after bacterial meningitis in childhood Article

Scandinavian Journal of Infectious Diseases, 34(5), 379-382.

R. Oostenbrink (Rianne), M. Maas (Mariëlle), K.G.M. Moons (Karel) and H.A. Moll (Henriëtte)

July 2002
The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery Review

J. Neudecker (J.), A.M. Koivusalo (Anna-Maria), A. Lacy (Antonio), M.J. McMahon (M.), B. Millat (B.), W. Schwenk (W.), M.C. Sauerland (Maria), E. Neugebauer, G. Bergamaschi, H.J. Bonjer (Jaap), et al.

July 2002
Relative bladder outlet obstruction Article

The Journal of Urology, 565-570.

R. Kranse (Ries) and R. van Mastrigt (Ron)

July 2002
Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer Article

European Journal of Cancer, 38(11), 1495-1500.

M.B. Polee (Marco), J. Verweij (Jaap), P.D. Siersema (Peter), H.W. Tilanus (Hugo), T.A.W. Splinter (Ted), G. Stoter (Gerrit) and A. van der Gaast (Ate)

July 2002
24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder Article

European Neuropsychopharmacology, 12(4), 273-278.

A.C. Volkers (Anita), J.H.M. Tulen (Joke), W.W. van den Broek (Walter), J.A. Bruijn (Jan), J. Passchier (Jan) and L. Pepplinkhuizen (Lolke)

July 2002
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin Article

European Journal of Cancer, 38(11), 1501-1511.

U. Keilholz (Ulrich), P. Martus (P.), C.J.A. Punt (Cornelis), W.H.J. Kruit (Wim), G. Mooser (G.), D. Schadendorf (Dirk), D. Lienard (Danielle), R. Dummer (Reinhard), J. Koller (J.), C. Voit (Christiane), et al.

July 2002
A New Explanation for the Difference Between SG and TTO Utilities Article

Health Economics, 11(5), 447-456.

H. Bleichrodt (Han)

July 2002

Previous

Next